Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options

BLOOD

Malcikova, J; Pavlova, S; Barbara, KV; Radova, L; Plevova, K; Kotaskova, J; Pal, K; Dvorackova, B; Zenatova, M; Hynst, J; Ondrouskova, E; Panovska, A; Brychtova, Y; Zavacka, K; Tichy, B; Tom, N; Mayer, J; Doubek, M; Pospisilova, S, 2021: Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. BLOOD 138(25), p. 2670 - 2685, doi: 10.1182/blood.2020009530

Research Groups:

Medical Genomics

CEITEC authors:

Lenka Radová, Ph.D.
Jana Kotašková, Ph.D.
Boris Tichý, Ph.D.
Prof. Michael Doubek, Ph.D.
Šárka Pavlová, Ph.D.